These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 28148582)
1. Gout - a guide for the general and acute physicians. Abhishek A; Roddy E; Doherty M Clin Med (Lond); 2017 Feb; 17(1):54-59. PubMed ID: 28148582 [TBL] [Abstract][Full Text] [Related]
2. 2011 recommendations for the diagnosis and management of gout and hyperuricemia. Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL Phys Sportsmed; 2011 Nov; 39(4):98-123. PubMed ID: 22293773 [TBL] [Abstract][Full Text] [Related]
3. Patients with gout can be cured in primary care. Rees F; Doherty M Practitioner; 2014 Dec; 258(1777):15-9, 2. PubMed ID: 25603588 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout. Pérez-Ruiz F; Jansen T; Tausche AK; Juárez-Campo M; Gurunath RK; Richette P Drugs Context; 2019; 8():212581. PubMed ID: 31191704 [TBL] [Abstract][Full Text] [Related]
5. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT). Christensen HD; Sheta HM; Morillon MB; Hansen IM Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121 [TBL] [Abstract][Full Text] [Related]
6. [Gout]. Tausche AK Z Rheumatol; 2022 Jun; 81(5):400-412. PubMed ID: 35596003 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to chronic hyperuricemia and gout. Grassi D; Pontremoli R; Bocale R; Ferri C; Desideri G High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):243-50. PubMed ID: 24696068 [TBL] [Abstract][Full Text] [Related]
8. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review. Keenan RT Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis, treatment, and prevention of gout. Hainer BL; Matheson E; Wilkes RT Am Fam Physician; 2014 Dec; 90(12):831-6. PubMed ID: 25591183 [TBL] [Abstract][Full Text] [Related]
10. Management of Gout and Hyperuricemia in CKD. Vargas-Santos AB; Neogi T Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346 [TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. Guma M; Dadpey B; Coras R; Mikuls TR; Hamilton B; Quehenberger O; Thorisdottir H; Bittleman D; Lauro K; Reilly SM; Liu-Bryan R; Terkeltaub R Arthritis Res Ther; 2022 Jul; 24(1):175. PubMed ID: 35879786 [TBL] [Abstract][Full Text] [Related]
12. Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares. Soskind R; Abazia DT; Bridgeman MB Expert Opin Pharmacother; 2017 Aug; 18(11):1115-1125. PubMed ID: 28658988 [TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia and gout. German DC; Holmes EW Med Clin North Am; 1986 Mar; 70(2):419-36. PubMed ID: 3512932 [TBL] [Abstract][Full Text] [Related]
14. Gout: an update. Eggebeen AT Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294 [TBL] [Abstract][Full Text] [Related]